Phase II Study of Bendamustine and Ofatumumab in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy.

Flinn, Ian W; Erter, Jack; Daniel, Davey B; Mace, Joseph R; Berdeja, Jesus G.
Oncologist; 24(8): 1035-e623, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31073022